{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:22:40Z","timestamp":1795112560925,"version":"4.10.3"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-025-00649-6","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:50:47Z","timestamp":1744887047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of the RING finger protein 213 gene in Moyamoya disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Xinpeng","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaosen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"649_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337. https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"649_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12975-019-00743-6","volume":"11","author":"OY Bang","year":"2020","unstructured":"Bang OY, Chung J-W, Kim DH, Won H-H, Yeon JY, Ki C-S, Shin HJ, Kim J-S, Hong SC, Kim D-K, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res. 2020;11:580\u20139. https:\/\/doi.org\/10.1007\/s12975-019-00743-6","journal-title":"Transl Stroke Res"},{"key":"649_CR3","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, Niu X, Liang F, Dai Y, Liang J, Li J, Wu X, Zheng H, Qi T, Sheng W. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain. 2023;146:4674\u201389. https:\/\/doi.org\/10.1093\/brain\/awad225","journal-title":"Brain"},{"key":"649_CR4","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3171\/FOC\/2008\/24\/2\/E16","volume":"24","author":"A Veeravagu","year":"2008","unstructured":"Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24:E16. https:\/\/doi.org\/10.3171\/FOC\/2008\/24\/2\/E16","journal-title":"Neurosurg Focus"},{"key":"649_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","volume":"112","author":"W Miao","year":"2010","unstructured":"Miao W, Zhao P-L, Zhang Y-S, Liu H-Y, Chang Y, Ma J, Huang Q-J, Lou Z-X. Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg. 2010;112:199\u2013203. https:\/\/doi.org\/10.1016\/j.clineuro.2009.11.009","journal-title":"Clin Neurol Neurosurg"},{"key":"649_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000445348","volume":"75","author":"J-W Chung","year":"2016","unstructured":"Chung J-W, Kim SJ, Bang OY, Kim KH, Ki C-S, Jeon P, Yeon JY, Kim J-S, Hong SC, Shin HJ. Determinants of basal collaterals in moyamoya disease: clinical and genetic factors. Eur Neurol. 2016;75:178\u201385. https:\/\/doi.org\/10.1159\/000445348","journal-title":"Eur Neurol"},{"key":"649_CR7","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","volume":"39","author":"ES Roach","year":"2008","unstructured":"Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, et al. Management of stroke in infants and children: a scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644\u201391. https:\/\/doi.org\/10.1161\/STROKEAHA.108.189696","journal-title":"Stroke"},{"key":"649_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21:747\u201358. https:\/\/doi.org\/10.1016\/S1474-4422(22)00165-X","journal-title":"Lancet Neurol"},{"key":"649_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S. 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society. Neurol Med Chir (Tokyo). 2022;62:165\u201370. https:\/\/doi.org\/10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"649_CR10","doi-asserted-by":"publisher","first-page":"e2415102","DOI":"10.1001\/jamanetworkopen.2024.15102","volume":"7","author":"YC Lim","year":"2024","unstructured":"Lim YC, Lee E, Song J. Outcomes of bypass surgery in adult moyamoya disease by onset type. JAMA Netw Open. 2024;7:e2415102. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.15102","journal-title":"JAMA Netw Open"},{"key":"649_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho W-S. Moyamoya disease: treatment and outcomes. J Stroke. 2016;18:21\u201330. https:\/\/doi.org\/10.5853\/jos.2015.01739","journal-title":"J Stroke"},{"key":"649_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132","journal-title":"J Hum Genet"},{"key":"649_CR13","doi-asserted-by":"publisher","unstructured":"Ahel J, Lehner A, Vogel A, Schleiffer A, Meinhart A, Haselbach D, Clausen T. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. Elife. 2020;9. https:\/\/doi.org\/10.7554\/eLife.56185","DOI":"10.7554\/eLife.56185"},{"key":"649_CR14","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542","journal-title":"PLoS ONE"},{"key":"649_CR15","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.013","volume":"27","author":"Y Wang","year":"2018","unstructured":"Wang Y, Mambiya M, Li Q, Yang L, Jia H, Han Y, Liu W. RNF213 p.R4810K polymorphism and the risk of moyamoya disease, intracranial major artery stenosis\/occlusion, and Quasi-Moyamoya disease: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27:2259\u201370. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.04.013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"649_CR16","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/srep04442","volume":"4","author":"D Morito","year":"2014","unstructured":"Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, Kinjo M, Fujiyoshi Y, Nagata K. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA\u2009+\u2009ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. https:\/\/doi.org\/10.1038\/srep04442","journal-title":"Sci Rep"},{"key":"649_CR17","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1038\/s41467-021-26061-w","volume":"12","author":"F Thery","year":"2021","unstructured":"Thery F, Martina L, Asselman C, Zhang Y, Vessely M, Repo H, Sedeyn K, Moschonas GD, Bredow C, Teo QW, et al. Ring finger protein 213 assembles into a sensor for isgylated proteins with antimicrobial activity. Nat Commun. 2021;12:5772. https:\/\/doi.org\/10.1038\/s41467-021-26061-w","journal-title":"Nat Commun"},{"key":"649_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03566-4","volume":"594","author":"EG Otten","year":"2021","unstructured":"Otten EG, Werner E, Crespillo-Casado A, Boyle KB, Dharamdasani V, Pathe C, Santhanam B, Randow F. Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection. Nature. 2021;594:111\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03566-4","journal-title":"Nature"},{"key":"649_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","volume":"556","author":"K-C Pao","year":"2018","unstructured":"Pao K-C, Wood NT, Knebel A, Rafie K, Stanley M, Mabbitt PD, Sundaramoorthy R, Hofmann K, van Aalten DMF, Virdee S. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. Nature. 2018;556:381\u20135. https:\/\/doi.org\/10.1038\/s41586-018-0026-1","journal-title":"Nature"},{"key":"649_CR20","doi-asserted-by":"publisher","unstructured":"Bhardwaj A, Banh RS, Zhang W, Sidhu SS, Neel BG. MMD-associated RNF213 SNPs encode dominant-negative alleles that globally impair ubiquitylation. Life Sci Alliance. 2022;5. https:\/\/doi.org\/10.26508\/lsa.202000807","DOI":"10.26508\/lsa.202000807"},{"key":"649_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28:939\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009","journal-title":"Trends Mol Med"},{"key":"649_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/302243","volume":"64","author":"H Ikeda","year":"1999","unstructured":"Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533\u20137.","journal-title":"Am J Hum Genet"},{"key":"649_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/s0387-7604(02)00224-3","volume":"25","author":"DI Zafeiriou","year":"2003","unstructured":"Zafeiriou DI, Ikeda H, Anastasiou A, Vargiami E, Vougiouklis N, Katzos G, Gombakis N, Gioula G, Matsushima Y, Kirkham FJ. Familial moyamoya disease in a Greek family. Brain Dev. 2003;25:288\u201390.","journal-title":"Brain Dev"},{"key":"649_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.STR.31.4.930","volume":"31","author":"T Yamauchi","year":"2000","unstructured":"Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930\u20135.","journal-title":"Stroke"},{"key":"649_CR25","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","volume":"70","author":"Y Mineharu","year":"2008","unstructured":"Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70:2357\u201363. https:\/\/doi.org\/10.1212\/01.wnl.0000291012.49986.f9","journal-title":"Neurology"},{"key":"649_CR26","doi-asserted-by":"publisher","unstructured":"Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, Kobayashi H, Kikuta K-I, Takagi Y, Hitomi T, Krischek B, et al. A rare Asian founder polymorphism of raptor may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15. https:\/\/doi.org\/10.1007\/s12199-009-0116-7","DOI":"10.1007\/s12199-009-0116-7"},{"key":"649_CR27","doi-asserted-by":"publisher","first-page":"107801","DOI":"10.1016\/j.clineuro.2023.107801","volume":"231","author":"X Jiang","year":"2023","unstructured":"Jiang X, Liu L, Ai S, Xie X, Deng J, Jiang Z, Teng B, Liu C, Huang H. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population. Clin Neurol Neurosurg. 2023;231:107801. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107801","journal-title":"Clin Neurol Neurosurg"},{"key":"649_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00438-016-1172-5","volume":"291","author":"X-S Sun","year":"2016","unstructured":"Sun X-S, Wen J, Li J-X, Lai R, Wang Y-F, Liu H-J, Sheng W-L. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies. Mol Genet Genomics. 2016;291:1193\u2013203. https:\/\/doi.org\/10.1007\/s00438-016-1172-5","journal-title":"Mol Genet Genomics"},{"key":"649_CR29","doi-asserted-by":"publisher","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M, Gu Y. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS ONE. 2012;7:e48179. https:\/\/doi.org\/10.1371\/journal.pone.0048179","journal-title":"PLoS ONE"},{"key":"649_CR30","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RLP, Leal SM, Wang GT, Regalado ES, Steinberg GK, Shendure J, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45:3200\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006244","journal-title":"Stroke"},{"key":"649_CR31","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/ajmg.a.37230","volume":"167A","author":"T Harel","year":"2015","unstructured":"Harel T, Posey JE, Graham BH, Walkiewicz M, Yang Y, Lalani SR, Belmont JW. Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant. Am J Med Genet A. 2015;167A:2742\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.37230","journal-title":"Am J Med Genet A"},{"key":"649_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.23736\/S0390-5616.16.03900-X","volume":"64","author":"A Raso","year":"2020","unstructured":"Raso A, Biassoni R, Mascelli S, Nozza P, Ugolotti E, Di Marco E, De Marco P, Merello E, Cama A, Pavanello M, et al. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. J Neurosurg Sci. 2020;64:165\u201372. https:\/\/doi.org\/10.23736\/S0390-5616.16.03900-X","journal-title":"J Neurosurg Sci"},{"key":"649_CR33","doi-asserted-by":"publisher","unstructured":"Guey S, Kraemer M, Herv\u00e9 D, Ludwig T, Kossorotoff M, Bergametti F, Schwitalla JC, Choi S, Broseus L, Callebaut I, et al. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 2017;25. https:\/\/doi.org\/10.1038\/ejhg.2017.92","DOI":"10.1038\/ejhg.2017.92"},{"key":"649_CR34","doi-asserted-by":"publisher","first-page":"e0164759","DOI":"10.1371\/journal.pone.0164759","volume":"11","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi H, Brozman M, Kyselov\u00e1 K, Viszlayov\u00e1 D, Morimoto T, Roubec M, \u0160koloud\u00edk D, Petrovi\u010dov\u00e1 A, Juskani\u010d D, Strauss J, et al. RNF213 rare variants in Slovakian and Czech moyamoya disease patients. PLoS ONE. 2016;11:e0164759. https:\/\/doi.org\/10.1371\/journal.pone.0164759","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"649_CR35","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/S0303-8467(97)00051-6","volume":"99","author":"TK Inoue","year":"1997","unstructured":"Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl 2):S234\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"649_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.STR.26.3.415","volume":"26","author":"M Aoyagi","year":"1995","unstructured":"Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K. Human leukocyte antigen in patients with moyamoya disease. Stroke. 1995;26:415\u20137.","journal-title":"Stroke"},{"key":"649_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3340\/jkns.2009.46.6.558","volume":"46","author":"SH Hong","year":"2009","unstructured":"Hong SH, Wang K-C, Kim S-K, Cho B-K, Park MH. Association of HLA-DR and -DQ genes with familial moyamoya disease in Koreans. J Korean Neurosurg Soc. 2009;46:558\u201363. https:\/\/doi.org\/10.3340\/jkns.2009.46.6.558","journal-title":"J Korean Neurosurg Soc"},{"key":"649_CR38","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3346\/jkms.2003.18.6.876","volume":"18","author":"H Han","year":"2003","unstructured":"Han H, Pyo C-W, Yoo D-S, Huh P-W, Cho K-S, Kim D-S. Associations of moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci. 2003;18:876\u201380.","journal-title":"J Korean Med Sci"},{"key":"649_CR39","doi-asserted-by":"crossref","unstructured":"Kang H-S, Kim S-K, Cho B-K, Kim Y-Y, Hwang Y-S, Wang K-C. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58.","DOI":"10.1227\/01.NEU.0000215854.66011.4F"},{"key":"649_CR40","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.4103\/0366-6999.191824","volume":"129","author":"Y-G Ma","year":"2016","unstructured":"Ma Y-G, Zhang Q, Yu L-B, Zhao J-Z. Role of ring finger protein 213 in moyamoya disease. Chin Med J (Engl). 2016;129:2497\u2013501. https:\/\/doi.org\/10.4103\/0366-6999.191824","journal-title":"Chin Med J (Engl)"},{"key":"649_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12199-017-0680-1","volume":"22","author":"X Liao","year":"2017","unstructured":"Liao X, Deng J, Dai W, Zhang T, Yan J. Rare variants of RNF213 and moyamoya\/non-moyamoya intracranial artery stenosis\/occlusion disease risk: a meta-analysis and systematic review. Environ Health Prev Med. 2017;22:75. https:\/\/doi.org\/10.1186\/s12199-017-0680-1","journal-title":"Environ Health Prev Med"},{"key":"649_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, et al. Homozygous c.14576G\u2009>\u2009A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78:803\u201310. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f","journal-title":"Neurology"},{"key":"649_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/0028-3886.107927","volume":"61","author":"J Ma","year":"2013","unstructured":"Ma J, Liu Y, Ma L, Huang S, Li H, You C. RNF213 polymorphism and moyamoya disease: a systematic review and meta-analysis. Neurol India. 2013;61:35\u20139. https:\/\/doi.org\/10.4103\/0028-3886.107927","journal-title":"Neurol India"},{"key":"649_CR44","doi-asserted-by":"publisher","first-page":"e0156607","DOI":"10.1371\/journal.pone.0156607","volume":"11","author":"OY Bang","year":"2016","unstructured":"Bang OY, Chung J-W, Cha J, Lee MJ, Yeon JY, Ki C-S, Jeon P, Kim J-S, Hong SC. A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis. PLoS ONE. 2016;11:e0156607. https:\/\/doi.org\/10.1371\/journal.pone.0156607","journal-title":"PLoS ONE"},{"key":"649_CR45","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/ajmg.a.37829","volume":"170","author":"H Fukushima","year":"2016","unstructured":"Fukushima H, Takenouchi T, Kosaki K. Homozygosity for moyamoya disease risk allele leads to Moyamoya disease with extracranial systemic and pulmonary vasculopathy. Am J Med Genet A. 2016;170:2453\u20136. https:\/\/doi.org\/10.1002\/ajmg.a.37829","journal-title":"Am J Med Genet A"},{"key":"649_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.chest.2017.09.023","volume":"153","author":"S-A Chang","year":"2018","unstructured":"Chang S-A, Song JS, Park TK, Yang JH, Kwon WC, Kim SR, Kim SM, Cha J, Jang SY, Cho YS, et al. Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of co-occurrence of moyamoya disease. Chest. 2018;153:404\u201313. https:\/\/doi.org\/10.1016\/j.chest.2017.09.023","journal-title":"Chest"},{"key":"649_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/STROKEAHA.118.023972","volume":"50","author":"L Grangeon","year":"2019","unstructured":"Grangeon L, Guey S, Schwitalla JC, Bergametti F, Arnould M, Corpechot M, Hadjadj J, Riant F, Aloui C, Drunat S, et al. Clinical and molecular features of 5 European multigenerational families with moyamoya angiopathy. Stroke. 2019;50:789\u201396. https:\/\/doi.org\/10.1161\/STROKEAHA.118.023972","journal-title":"Stroke"},{"key":"649_CR48","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1038\/s41598-017-03278-8","volume":"7","author":"L Weng","year":"2017","unstructured":"Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, Wang X, Chen X, Zheng W, Xu X, et al. Association of increased Treg and Th17 with pathogenesis of moyamoya disease. Sci Rep. 2017;7:3071. https:\/\/doi.org\/10.1038\/s41598-017-03278-8","journal-title":"Sci Rep"},{"key":"649_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/archneur.60.3.431","volume":"60","author":"S Palacio","year":"2003","unstructured":"Palacio S, Hart RG, Vollmer DG, Kagan-Hallet K. Late-developing cerebral arteropathy after pyogenic meningitis. Arch Neurol. 2003;60:431\u20133.","journal-title":"Arch Neurol"},{"key":"649_CR50","first-page":"179","volume":"157","author":"L Kerr","year":"1992","unstructured":"Kerr L, Filloux FM. Cerebral infarction as a remote complication of childhood haemophilus influenzae meningitis. West J Med. 1992;157:179\u201382.","journal-title":"West J Med"},{"key":"649_CR51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/jnnp.2004.041046","volume":"76","author":"T Czartoski","year":"2005","unstructured":"Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry. 2005;76:256\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"649_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/0976-3147.71726","volume":"1","author":"FY Khan","year":"2010","unstructured":"Khan FY, Kamal H, Musa R, Hayati A. Moyamoya syndrome in a known case of pulmonary tuberculosis. J Neurosci Rural Pract. 2010;1:105\u20138. https:\/\/doi.org\/10.4103\/0976-3147.71726","journal-title":"J Neurosci Rural Pract"},{"issue":"Suppl 2","key":"649_CR53","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/S0303-8467(97)00048-6","volume":"99","author":"H Yamada","year":"1997","unstructured":"Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, Hattori T, Andoh T, Sakai N. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg. 1997;99(Suppl 2):S221\u20134.","journal-title":"Clin Neurol Neurosurg"},{"key":"649_CR54","doi-asserted-by":"publisher","unstructured":"Pinardi F, Stracciari A, Spinardi L, Guarino M. Postpneumococcal moyamoya syndrome case report and review of the postinfective cases. BMJ Case Rep. 2013;2013. https:\/\/doi.org\/10.1136\/bcr-2012-006726","DOI":"10.1136\/bcr-2012-006726"},{"key":"649_CR55","doi-asserted-by":"publisher","first-page":"104549","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104549","volume":"29","author":"I Echizenya","year":"2020","unstructured":"Echizenya I, Tokairin K, Kawabori M, Kazumata K, Houkin K. Reversible cerebral angiopathy after viral infection in a pediatric patient with genetic variant of RNF213. J Stroke Cerebrovasc Dis. 2020;29:104549. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.104549","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"649_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0387-7604(02)00005-0","volume":"24","author":"M Ueno","year":"2002","unstructured":"Ueno M, Oka A, Koeda T, Okamoto R, Takeshita K. Unilateral occlusion of the middle cerebral artery after varicella-zoster virus infection. Brain Dev. 2002;24:106\u20138.","journal-title":"Brain Dev"},{"key":"649_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/brain\/awn313","volume":"132","author":"KPJ Braun","year":"2009","unstructured":"Braun KPJ, Bulder MMM, Chabrier S, Kirkham FJ, Uiterwaal CSP, Tardieu M, S\u00e9bire G. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009;132:544\u201357. https:\/\/doi.org\/10.1093\/brain\/awn313","journal-title":"Brain"},{"issue":"Suppl 2","key":"649_CR58","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/S0303-8467(97)00049-8","volume":"99","author":"T Tanigawara","year":"1997","unstructured":"Tanigawara T, Yamada H, Sakai N, Andoh T, Deguchi K, Iwamura M. Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl 2):S225\u20138.","journal-title":"Clin Neurol Neurosurg"},{"key":"649_CR59","doi-asserted-by":"publisher","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, Imai H, Sone M, Taura D, Harada KH, et al. Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015;4. https:\/\/doi.org\/10.1161\/JAHA.115.002146","DOI":"10.1161\/JAHA.115.002146"},{"key":"649_CR60","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.1038\/srep13191","volume":"5","author":"K Ohkubo","year":"2015","unstructured":"Ohkubo K, Sakai Y, Inoue H, Akamine S, Ishizaki Y, Matsushita Y, Sanefuji M, Torisu H, Ihara K, Sardiello M, et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep. 2015;5:13191. https:\/\/doi.org\/10.1038\/srep13191","journal-title":"Sci Rep"},{"key":"649_CR61","doi-asserted-by":"publisher","unstructured":"Bosch M, S\u00e1nchez-\u00c1lvarez M, Fajardo A, Kapetanovic R, Steiner B, Dutra F, Moreira L, L\u00f3pez JA, Campo R, Mar\u00ed M, et al. Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense. Science. 2020;370. https:\/\/doi.org\/10.1126\/science.aay8085","DOI":"10.1126\/science.aay8085"},{"key":"649_CR62","doi-asserted-by":"publisher","first-page":"145340","DOI":"10.1016\/j.gene.2020.145340","volume":"771","author":"P Sarkar","year":"2021","unstructured":"Sarkar P, Thirumurugan K. New insights into TNF\u03b1\/PTP1B and PPAR\u03b3 pathway through RNF213- a link between inflammation, obesity, insulin resistance, and moyamoya disease. Gene. 2021;771:145340. https:\/\/doi.org\/10.1016\/j.gene.2020.145340","journal-title":"Gene"},{"key":"649_CR63","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/01.STR.27.10.1750","volume":"27","author":"M Aoyagi","year":"1996","unstructured":"Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke. 1996;27:1750\u20134.","journal-title":"Stroke"},{"key":"649_CR64","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1038\/s41467-024-50392-z","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Zhu X, Sheng J, Fu Y, Nie D, You X, Chen Y, Yang X, Ling Q, Zhang H, et al. RNF213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1. Nat Commun. 2024;15:5961. https:\/\/doi.org\/10.1038\/s41467-024-50392-z","journal-title":"Nat Commun"},{"key":"649_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00335-020-09856-y","volume":"32","author":"D Houzelstein","year":"2021","unstructured":"Houzelstein D, Simon-Chazottes D, Batista L, Tokuda S, Langa Vives F, Flamand M, Montagutelli X, Panthier J-J. The ring finger protein 213 gene (Rnf213) contributes to rift valley fever resistance in mice. Mamm Genome. 2021;32:30\u20137. https:\/\/doi.org\/10.1007\/s00335-020-09856-y","journal-title":"Mamm Genome"},{"key":"649_CR66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2022.04.007","volume":"609","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Habu T, Kim J, Okuda H, Oikawa S, Murata M, Koizumi A, Kobayashi H. Suppression of RNF213, a susceptibility gene for moyamoya disease, inhibits endoplasmic reticulum stress through SEL1L upregulation. Biochem Biophys Res Commun. 2022;609:62\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.007","journal-title":"Biochem Biophys Res Commun"},{"key":"649_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"key":"649_CR68","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.110.608257","journal-title":"Stroke"},{"key":"649_CR69","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell. 2015;163:1064\u201378. https:\/\/doi.org\/10.1016\/j.cell.2015.10.067","journal-title":"Cell"},{"key":"649_CR70","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557\u201361. https:\/\/doi.org\/10.1038\/nature09522","journal-title":"Nature"},{"key":"649_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/neuonc\/noaa274","volume":"23","author":"N Wagle","year":"2021","unstructured":"Wagle N, Kesari S. Breaking down the blood-brain barrier. Neuro Oncol. 2021;23:6. https:\/\/doi.org\/10.1093\/neuonc\/noaa274","journal-title":"Neuro Oncol"},{"key":"649_CR72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12974-024-03261-x","volume":"21","author":"X Huang","year":"2024","unstructured":"Huang X, Wei P, Fang C, Yu M, Yang S, Qiu L, Wang Y, Xu A, Hoo RLC, Chang J. Compromised endothelial Wnt\/\u03b2-catenin signaling mediates the blood-brain barrier disruption and leads to neuroinflammation in endotoxemia. J Neuroinflammation. 2024;21:265. https:\/\/doi.org\/10.1186\/s12974-024-03261-x","journal-title":"J Neuroinflammation"},{"key":"649_CR73","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338. https:\/\/doi.org\/10.1038\/nrn3114","journal-title":"Nat Rev Neurosci"},{"key":"649_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68:409\u201327. https:\/\/doi.org\/10.1016\/j.neuron.2010.09.043","journal-title":"Neuron"},{"key":"649_CR75","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562\u20136. https:\/\/doi.org\/10.1038\/nature09513","journal-title":"Nature"},{"key":"649_CR76","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19:771\u201383. https:\/\/doi.org\/10.1038\/nn.4288","journal-title":"Nat Neurosci"},{"key":"649_CR77","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00701-019-03811-w","volume":"161","author":"A Narducci","year":"2019","unstructured":"Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P. In vivo demonstration of blood-brain barrier impairment in moyamoya disease. Acta Neurochir (Wien). 2019;161:371\u20138. https:\/\/doi.org\/10.1007\/s00701-019-03811-w","journal-title":"Acta Neurochir (Wien)"},{"key":"649_CR78","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00701-020-04480-w","volume":"162","author":"X Lu","year":"2020","unstructured":"Lu X, Huang Y, Zhou P, Hui P, Wang Z. Decreased cortical perfusion in areas with blood-brain barrier dysfunction in moyamoya disease. Acta Neurochir (Wien). 2020;162:2565\u201372. https:\/\/doi.org\/10.1007\/s00701-020-04480-w","journal-title":"Acta Neurochir (Wien)"},{"key":"649_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Fujimura M, Kim S-K. The pathophysiology of moyamoya disease: an update. J Stroke. 2016;18:12\u201320. https:\/\/doi.org\/10.5853\/jos.2015.01760","journal-title":"J Stroke"},{"key":"649_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fphys.2019.00002","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Huang C, Wu Y, Chen B, Zhang W, Zhang J. Autophagy protects the blood-brain barrier through regulating the dynamic of Claudin-5 in short-term starvation. Front Physiol. 2019;10:2. https:\/\/doi.org\/10.3389\/fphys.2019.00002","journal-title":"Front Physiol"},{"key":"649_CR81","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1038\/s41598-018-22064-8","volume":"8","author":"T Morimoto","year":"2018","unstructured":"Morimoto T, Enmi J-I, Hattori Y, Iguchi S, Saito S, Harada KH, Okuda H, Mineharu Y, Takagi Y, Youssefian S, et al. Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep. 2018;8:3607. https:\/\/doi.org\/10.1038\/s41598-018-22064-8","journal-title":"Sci Rep"},{"key":"649_CR82","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3171\/2018.8.PEDS1883","volume":"23","author":"SA Choi","year":"2019","unstructured":"Choi SA, Chong S, Kwak PA, Moon YJ, Jangra A, Phi JH, Lee JY, Park S-H, Kim S-K. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model. J Neurosurg Pediatr. 2019;23:204\u201313. https:\/\/doi.org\/10.3171\/2018.8.PEDS1883","journal-title":"J Neurosurg Pediatr"},{"key":"649_CR83","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R, Cortez Ghio S, Brodeur A, Touzel Desch\u00eanes L, Le-Bel G, Phillips DE, Milot G, Dion PA, et al. Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke. 2022;53:1263\u201375. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032691","journal-title":"Stroke"},{"key":"649_CR84","doi-asserted-by":"publisher","unstructured":"Fujihara K, Bennett JL, de Seze J, Haramura M, Kleiter I, Weinshenker BG, Kang D, Mughal T, Yamamura T. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology. Neurol Neuroimmunol Neuroinflamm. 2020;7. https:\/\/doi.org\/10.1212\/NXI.0000000000000841","DOI":"10.1212\/NXI.0000000000000841"},{"key":"649_CR85","doi-asserted-by":"publisher","first-page":"e101815","DOI":"10.1371\/journal.pone.0101815","volume":"9","author":"KD Rochfort","year":"2014","unstructured":"Rochfort KD, Collins LE, Murphy RP, Cummins PM. Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS ONE. 2014;9:e101815. https:\/\/doi.org\/10.1371\/journal.pone.0101815","journal-title":"PLoS ONE"},{"key":"649_CR86","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/01.STR.27.12.2160","volume":"27","author":"T Yoshimoto","year":"1996","unstructured":"Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in moyamoya disease. Stroke. 1996;27:2160\u20135.","journal-title":"Stroke"},{"key":"649_CR87","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvp241","volume":"84","author":"S Apostolakis","year":"2009","unstructured":"Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009;84:353\u201360. https:\/\/doi.org\/10.1093\/cvr\/cvp241","journal-title":"Cardiovasc Res"},{"key":"649_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/156720207779940716","volume":"4","author":"A Al-Bahrani","year":"2007","unstructured":"Al-Bahrani A, Taha S, Shaath H, Bakhiet M. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr Neurovasc Res. 2007;4:31\u20137.","journal-title":"Curr Neurovasc Res"},{"key":"649_CR89","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1111\/jcmm.17989","volume":"27","author":"H Wang","year":"2023","unstructured":"Wang H, Sun W, Li F, Jiang P, Wang L, Zhou N, Feng L. Bradykinin-bradykinin receptor (B1R) signalling is involved in the blood-brain barrier disruption in moyamoya disease. J Cell Mol Med. 2023;27:4069\u201379. https:\/\/doi.org\/10.1111\/jcmm.17989","journal-title":"J Cell Mol Med"},{"key":"649_CR90","doi-asserted-by":"crossref","unstructured":"St Goar FG, Gominak SC, Potkin BN. Bilateral aortoostial coronary artery disease: moyamoya of the heart? Am J Cardiol. 1999;83.","DOI":"10.1016\/S0002-9149(99)00081-8"},{"key":"649_CR91","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/CIRCULATIONAHA.112.136473","volume":"127","author":"J-H Lee","year":"2013","unstructured":"Lee J-H, Youn T-J, Yoon YE, Park JJ, Hong SJ, Chun EJ, Choi SI, Cho Y-S, Cho G-Y, Chae I-H, et al. Coronary artery stenosis in moyamoya disease: tissue characterization by 256-slice multi-detector CT and virtual histology. Circulation. 2013;127:2063\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.136473","journal-title":"Circulation"},{"key":"649_CR92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejpn.2015.11.002","volume":"20","author":"JW Baek","year":"2016","unstructured":"Baek JW, Jo K-I, Park JJ, Jeon P, Kim KH. Prevalence and clinical implications of renal artery stenosis in pediatric moyamoya disease. Eur J Paediatr Neurol. 2016;20:20\u20134. https:\/\/doi.org\/10.1016\/j.ejpn.2015.11.002","journal-title":"Eur J Paediatr Neurol"},{"key":"649_CR93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, Kikuchi A, Arai-Ichinoi N, Kure S, Tominaga T. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease. Brain Res. 2014;1552:64\u201371. https:\/\/doi.org\/10.1016\/j.brainres.2014.01.011","journal-title":"Brain Res"},{"key":"649_CR94","doi-asserted-by":"publisher","unstructured":"Lee M-J, Fallen S, Zhou Y, Baxter D, Scherler K, Kuo M-F, Wang K. The impact of moyamoya disease and RNF213 mutations on the spectrum of plasma protein and MicroRNA. J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/jcm8101648","DOI":"10.3390\/jcm8101648"},{"key":"649_CR95","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.brainres.2015.07.039","volume":"1624","author":"A Kanoke","year":"2015","unstructured":"Kanoke A, Fujimura M, Niizuma K, Ito A, Sakata H, Sato-Maeda M, Morita-Fujimura Y, Kure S, Tominaga T. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Brain Res. 2015;1624:497\u2013505. https:\/\/doi.org\/10.1016\/j.brainres.2015.07.039","journal-title":"Brain Res"},{"key":"649_CR96","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.brainres.2014.11.014","volume":"1594","author":"A Ito","year":"2015","unstructured":"Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, Kikuchi A, Kure S, Tominaga T. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease. Brain Res. 2015;1594:310\u201320. https:\/\/doi.org\/10.1016\/j.brainres.2014.11.014","journal-title":"Brain Res"},{"key":"649_CR97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2015.10.055","volume":"1630","author":"M Sato-Maeda","year":"2016","unstructured":"Sato-Maeda M, Fujimura M, Kanoke A, Morita-Fujimura Y, Niizuma K, Tominaga T. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease. Brain Res. 2016;1630:50\u20135. https:\/\/doi.org\/10.1016\/j.brainres.2015.10.055","journal-title":"Brain Res"},{"key":"649_CR98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, et al. Downregulation of securin by the variant RNF213 R4810K (rs112735431, G\u2009>\u2009A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun. 2013;438:13\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.004","journal-title":"Biochem Biophys Res Commun"},{"key":"649_CR99","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2016.04.051","volume":"1644","author":"J Wen","year":"2016","unstructured":"Wen J, Sun X, Chen H, Liu H, Lai R, Li J, Wang Y, Zhang J, Sheng W. Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 2016;1644:70\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.051","journal-title":"Brain Res"},{"key":"649_CR100","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1177\/0271678X20914996","volume":"41","author":"J Lin","year":"2021","unstructured":"Lin J, Liang J, Wen J, Luo M, Li J, Sun X, Xu X, Li J, Wang D, Wang J, et al. Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish. J Cereb Blood Flow Metab. 2021;41:1251\u201363. https:\/\/doi.org\/10.1177\/0271678X20914996","journal-title":"J Cereb Blood Flow Metab"},{"key":"649_CR101","doi-asserted-by":"publisher","first-page":"105305","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"K Tokairin","year":"2020","unstructured":"Tokairin K, Hamauchi S, Ito M, Kazumata K, Sugiyama T, Nakayama N, Kawabori M, Osanai T, Houkin K. Vascular smooth muscle cell derived from IPS cell of moyamoya Disease - comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis. 2020;29:105305. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105305","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"649_CR102","doi-asserted-by":"publisher","first-page":"e0169714","DOI":"10.1371\/journal.pone.0169714","volume":"12","author":"JH Phi","year":"2017","unstructured":"Phi JH, Suzuki N, Moon YJ, Park AK, Wang K-C, Lee JY, Choi S-A, Chong S, Shirane R, Kim S-K. Chemokine ligand 5 (CCL5) derived from endothelial colony-forming cells (ECFCs) mediates recruitment of smooth muscle progenitor cells (SPCs) toward critical vascular locations in moyamoya disease. PLoS ONE. 2017;12:e0169714. https:\/\/doi.org\/10.1371\/journal.pone.0169714","journal-title":"PLoS ONE"},{"key":"649_CR103","doi-asserted-by":"publisher","unstructured":"Liu Y, Huang Y, Zhang X, Ma X, He X, Gan C, Zou X, Wang S, Shu K, Lei T, et al. CircZXDC promotes vascular smooth muscle cell transdifferentiation via regulating miRNA-125a-3p\/ABCC6 in moyamoya disease. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11233792","DOI":"10.3390\/cells11233792"},{"key":"649_CR104","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1161\/STROKEAHA.121.038066","volume":"53","author":"Y Xue","year":"2022","unstructured":"Xue Y, Zeng C, Ge P, Liu C, Li J, Zhang Y, Zhang D, Zhang Q, Zhao J. Association of RNF213 variants with periventricular anastomosis in moyamoya disease. Stroke. 2022;53:2906\u201316. https:\/\/doi.org\/10.1161\/STROKEAHA.121.038066","journal-title":"Stroke"},{"key":"649_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000503250","volume":"48","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhang Q, Zhao J. Association between p.R4810K variant and postoperative collateral formation in patients with moyamoya disease. Cerebrovasc Dis. 2019;48:77\u201384. https:\/\/doi.org\/10.1159\/000503250","journal-title":"Cerebrovasc Dis"},{"key":"649_CR106","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3171\/2021.3.JNS203913","volume":"136","author":"Y Mineharu","year":"2022","unstructured":"Mineharu Y, Takagi Y, Koizumi A, Morimoto T, Funaki T, Hishikawa T, Araki Y, Hasegawa H, Takahashi JC, Kuroda S, et al. Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan study group. J Neurosurg. 2022;136:1005\u201314. https:\/\/doi.org\/10.3171\/2021.3.JNS203913","journal-title":"J Neurosurg"},{"key":"649_CR107","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12975-021-00956-8","volume":"13","author":"D Ishigami","year":"2022","unstructured":"Ishigami D, Miyawaki S, Imai H, Shimizu M, Hongo H, Dofuku S, Ohara K, Teranishi Y, Shimada D, Koizumi S, et al. RNF213 p.Arg4810Lys heterozygosity in moyamoya disease indicates early onset and bilateral cerebrovascular events. Transl Stroke Res. 2022;13:410\u20139. https:\/\/doi.org\/10.1007\/s12975-021-00956-8","journal-title":"Transl Stroke Res"},{"key":"649_CR108","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10143-022-01749-9","volume":"45","author":"M Ito","year":"2022","unstructured":"Ito M, Kawabori M, Sugiyama T, Tokairin K, Tatezawa R, Uchino H, Kazumata K, Houkin K, Fujimura M. Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult moyamoya disease. Neurosurg Rev. 2022;45:2305\u201313. https:\/\/doi.org\/10.1007\/s10143-022-01749-9","journal-title":"Neurosurg Rev"},{"key":"649_CR109","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T, Neuroinflammation. Stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke. 2022;53:1473\u201386. https:\/\/doi.org\/10.1161\/STROKEAHA.122.036946","journal-title":"Stroke"},{"key":"649_CR110","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1007\/s11064-023-03923-x","volume":"48","author":"X Guo","year":"2023","unstructured":"Guo X, Liu R, Jia M, Wang Q, Wu J. Ischemia reperfusion injury induced blood brain barrier dysfunction and the involved molecular mechanism. Neurochem Res. 2023;48:2320\u201334. https:\/\/doi.org\/10.1007\/s11064-023-03923-x","journal-title":"Neurochem Res"},{"key":"649_CR111","doi-asserted-by":"publisher","first-page":"106509","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106509","volume":"31","author":"Y Nakamura","year":"2022","unstructured":"Nakamura Y, Mineharu Y, Kamata T, Funaki T, Miyamoto S, Koizumi A, Harada KH. Lack of association between seropositivity of vasculopathy-related viruses and moyamoya disease. J Stroke Cerebrovasc Dis. 2022;31:106509. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2022.106509","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"649_CR112","doi-asserted-by":"publisher","first-page":"eabq0712","DOI":"10.1126\/sciadv.abq0712","volume":"9","author":"SX Shi","year":"2023","unstructured":"Shi SX, Xiu Y, Li Y, Yuan M, Shi K, Liu Q, Wang X, Jin W-N. CD4\u2009+\u2009T cells aggravate hemorrhagic brain injury. Sci Adv. 2023;9:eabq0712. https:\/\/doi.org\/10.1126\/sciadv.abq0712","journal-title":"Sci Adv"},{"key":"649_CR113","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1007\/s12035-023-03480-y","volume":"60","author":"W Li","year":"2023","unstructured":"Li W, Niu X, Dai Y, Wu X, Li J, Sheng W. Rnf-213 knockout induces pericyte reduction and blood-brain barrier impairment in mouse. Mol Neurobiol. 2023;60:6188\u2013200. https:\/\/doi.org\/10.1007\/s12035-023-03480-y","journal-title":"Mol Neurobiol"},{"key":"649_CR114","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/aji.12547","volume":"76","author":"C Bean","year":"2016","unstructured":"Bean C, Spencer S-K, Bowles T, Kyle PB, Williams JM, Gibbens J, Wallace K. Inhibition of T-cell activation attenuates hypertension, TNF\u03b1, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance. Am J Reprod Immunol. 2016;76:272\u20139. https:\/\/doi.org\/10.1111\/aji.12547","journal-title":"Am J Reprod Immunol"},{"key":"649_CR115","doi-asserted-by":"publisher","unstructured":"Presta I, Vismara M, Novellino F, Donato A, Zaffino P, Scali E, Pirrone KC, Spadea MF, Malara N, Donato G. Innate immunity cells and the neurovascular unit. Int J Mol Sci. 2018;19. https:\/\/doi.org\/10.3390\/ijms19123856","DOI":"10.3390\/ijms19123856"},{"key":"649_CR116","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/13550280801993630","volume":"14","author":"S Nakamuta","year":"2008","unstructured":"Nakamuta S, Endo H, Higashi Y, Kousaka A, Yamada H, Yano M, Kido H. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of Zonula occludens-1 and\u2013\u20092 in human brain microvascular endothelial cells. J Neurovirol. 2008;14:186\u201395. https:\/\/doi.org\/10.1080\/13550280801993630","journal-title":"J Neurovirol"},{"key":"649_CR117","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1173196","volume":"325","author":"M Coureuil","year":"2009","unstructured":"Coureuil M, Mikaty G, Miller F, L\u00e9cuyer H, Bernard C, Bourdoulous S, Dum\u00e9nil G, M\u00e8ge R-M, Weksler BB, Romero IA, et al. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science. 2009;325:83\u20137. https:\/\/doi.org\/10.1126\/science.1173196","journal-title":"Science"},{"key":"649_CR118","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","volume":"585","author":"C Larochelle","year":"2011","unstructured":"Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011;585:3770\u201380. https:\/\/doi.org\/10.1016\/j.febslet.2011.04.066","journal-title":"FEBS Lett"},{"key":"649_CR119","doi-asserted-by":"publisher","unstructured":"Labus J, W\u00f6ltje K, Stolte KN, H\u00e4ckel S, Kim KS, Hildmann A, Danker K. IL-1\u03b2 promotes transendothelial migration of PBMCs by upregulation of the FN\/\u03b15\u03b21 signalling pathway in immortalised human brain microvascular endothelial cells. Exp Cell Res. 2018;373. https:\/\/doi.org\/10.1016\/j.yexcr.2018.10.002","DOI":"10.1016\/j.yexcr.2018.10.002"},{"key":"649_CR120","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1096\/fj.201801595RR","volume":"33","author":"S Tan","year":"2019","unstructured":"Tan S, Shan Y, Lin Y, Liao S, Zhang B, Zeng Q, Wang Y, Deng Z, Chen C, Hu X, et al. Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A. FASEB J. 2019;33:4376\u201387. https:\/\/doi.org\/10.1096\/fj.201801595RR","journal-title":"FASEB J"},{"key":"649_CR121","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneumeth.2014.03.002","volume":"228","author":"J Labus","year":"2014","unstructured":"Labus J, H\u00e4ckel S, Lucka L, Danker K. Interleukin-1\u03b2 induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model. J Neurosci Methods. 2014;228:35\u201345. https:\/\/doi.org\/10.1016\/j.jneumeth.2014.03.002","journal-title":"J Neurosci Methods"},{"key":"649_CR122","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20:1752\u201360. https:\/\/doi.org\/10.1038\/s41593-017-0010-3","journal-title":"Nat Neurosci"},{"key":"649_CR123","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/cns.13101","volume":"25","author":"W Chen","year":"2019","unstructured":"Chen W, Ju X-Z, Lu Y, Ding X-W, Miao C-H, Chen J-W. Propofol improved hypoxia-impaired integrity of blood-brain barrier via modulating the expression and phosphorylation of Zonula occludens-1. CNS Neurosci Ther. 2019;25:704\u201313. https:\/\/doi.org\/10.1111\/cns.13101","journal-title":"CNS Neurosci Ther"},{"key":"649_CR124","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/glia.23611","volume":"67","author":"D Farfara","year":"2019","unstructured":"Farfara D, Feierman E, Richards A, Revenko AS, MacLeod RA, Norris EH, Strickland S. Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits. Glia. 2019;67:1359\u201373. https:\/\/doi.org\/10.1002\/glia.23611","journal-title":"Glia"},{"key":"649_CR125","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.biopha.2018.05.143","volume":"105","author":"J Wang","year":"2018","unstructured":"Wang J, Xing H, Wan L, Jiang X, Wang C, Wu Y. Treatment targets for M2 microglia polarization in ischemic stroke. Biomed Pharmacother. 2018;105:518\u201325. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.143","journal-title":"Biomed Pharmacother"},{"key":"649_CR126","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","volume":"9","author":"SR Subramaniam","year":"2017","unstructured":"Subramaniam SR, Federoff HJ. Targeting microglial activation states as a therapeutic avenue in Parkinson\u2019s disease. Front Aging Neurosci. 2017;9:176. https:\/\/doi.org\/10.3389\/fnagi.2017.00176","journal-title":"Front Aging Neurosci"},{"key":"649_CR127","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/cns.13261","volume":"25","author":"Z-J Liu","year":"2019","unstructured":"Liu Z-J, Ran Y-Y, Qie S-Y, Gong W-J, Gao F-H, Ding Z-T, Xi J-N. Melatonin protects against ischemic stroke by modulating microglia\/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther. 2019;25:1353\u201362. https:\/\/doi.org\/10.1111\/cns.13261","journal-title":"CNS Neurosci Ther"},{"key":"649_CR128","doi-asserted-by":"publisher","first-page":"412","DOI":"10.14336\/AD.2017.0926","volume":"9","author":"C Zhang","year":"2018","unstructured":"Zhang C, Brandon NR, Koper K, Tang P, Xu Y, Dou H. Invasion of peripheral immune cells into brain parenchyma after cardiac arrest and resuscitation. Aging Dis. 2018;9:412\u201325. https:\/\/doi.org\/10.14336\/AD.2017.0926","journal-title":"Aging Dis"},{"key":"649_CR129","doi-asserted-by":"publisher","first-page":"103973","DOI":"10.1016\/j.mvr.2019.103973","volume":"129","author":"ECG Victoria","year":"2020","unstructured":"Victoria ECG, Toscano ECB, Oliveira FMS, de Carvalho BA, Caliari MV, Teixeira AL, de Miranda AS, Rachid MA. Up-regulation of brain cytokines and metalloproteinases 1 and 2 contributes to neurological deficit and brain damage in transient ischemic stroke. Microvasc Res. 2020;129:103973. https:\/\/doi.org\/10.1016\/j.mvr.2019.103973","journal-title":"Microvasc Res"},{"key":"649_CR130","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-024-07314-2","volume":"629","author":"C Wei","year":"2024","unstructured":"Wei C, Jiang W, Wang R, Zhong H, He H, Gao X, Zhong S, Yu F, Guo Q, Zhang L, et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown. Nature. 2024;629:893\u2013900. https:\/\/doi.org\/10.1038\/s41586-024-07314-2","journal-title":"Nature"},{"key":"649_CR131","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18:2489\u2013501. https:\/\/doi.org\/10.1038\/s41423-021-00757-x","journal-title":"Cell Mol Immunol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:50:49Z","timestamp":1744887049000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00649-6","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}